Introduction
Voltage-gated sodium (Na þ ) channels are essential to the initiation and propagation of the action potential (AP) in excitable cells. Impaired function of the cardiac Na þ channel reduces cardiac excitability and may evoke lethal arrhythmias. This applies both to inherited arrhythmia syndromes based on loss-of-function causing mutations in SCN5A, the gene which encodes the poreforming a-subunit of the human cardiac Na þ channel (Na v 1.5), and to acquired disease, e.g. heart failure (HF). 1 These insights have spawned recent studies aimed at elucidating the regulatory processes that govern cardiac Na þ channel function. Of note, Na þ channels in vivo are not isolated functional units in the lipid plasma membrane, but are associated with several other proteins that participate in cell adhesion, signal transduction, and cytoskeleton anchoring. 2 The cytoskeleton with its network of fibrous proteins is not only essential for cell morphology, cellular motility, intracellular transport, and cell division, but it also modulates Na þ channel function. Exposure to agents that either destroy or stabilize its major components (actin microfilaments and microtubules) causes changes in Na þ current (I Na ) density and functional properties (gating) in several tissues. 3 -9 Accordingly, treatment with the anticancer drug taxol (TXL), which causes tubulin polymerization, is regularly associated with cardiac conduction disorders and arrhythmias which are consistent with I Na reduction. 10, 11 Yet, studies on the effects of tubulin polymerization by TXL on cardiac Na þ channel function are sparse. 4 The cardiac Na þ channel macromolecular complex also contains one or more small auxiliary b-subunits. Four genes that encode the subunits b 1 -b 4 have been identified and are all expressed in the human heart. 12 b 1 and b 2 associate with Na v 1.5 in ventricular cardiomyocytes, as demonstrated by co-immunoprecipitation. 13 Na þ channel b-subunits regulate Na þ channel expression and gating and also serve as cell adhesion molecules and scaffolds to bring other proteins to the channel, 14 e.g.
by interacting with cytoskeletal proteins called ankyrins. 15, 16 We hypothesized that the regulation of the cardiac Na þ channel function by the cytoskeleton may involve interactions with the b 1 -subunit. Thus, we studied whether microtubule polymerization alters I Na density and gating, and whether these effects involve b 1 -subunits.
Methods

Heterologous expression of cardiac Na 1 channels
SCN5A cDNA was cloned into the pCGI vector for bicistronic expression of Na v 1.5 and green fluorescent protein, as described previously. 17 Human embryonic kidney (HEK293) cells were transiently transfected with 0.5 mg of SCN5A cDNA alone (Na v 1.5), or together with 0.5 mg SCN1B cDNA (Na v 1.5 þ b 1 , SCN1B was kindly provided by Dr Jeff R. Balser, Vanderbilt University, Nashville TN, USA) using lipofectamine (Gibco BRL, Life Technologies). Transfected HEK293 cells were cultured for 1 or 2 days, as described previously. 18 To study the effects of tubulin polymerization on cardiac Na þ channel function and the role of the b 1 -subunit therein, Na v 1.5 and Na v 1.5 þ b 1 were incubated with 100 mM TXL (Sigma Co.), a microtubule stabilizer which enhances tubulin polymerization into stable microtubules. 19 After 4 h incubation with TXL at 378C, cells were used for electrophysiological investigation and immunocytochemistry.
Neonatal rat cardiomyocytes
Neonatal rat ventricular cardiomyocytes (NRCs) were isolated from hearts of 1 -2-day-old Wistar rats and kept in culture as described previously. 20 After overnight incubation at 378C with 100 mM TXL, NRCs were used for electrophysiological investigation and immunocytochemistry. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by the institutional animal experiments committee.
Electrophysiological measurements and data analysis
I Na was recorded in the whole-cell configuration of the patch-clamp technique. Experiments were performed at room temperature (208C) with the use of an Axopatch 200B amplifier (Axon Instruments). Series resistance was compensated for !80%, and patch electrodes had a tip resistance of 2 MV. Currents were filtered at 5 kHz and digitized at 20 kHz. Voltage control, data acquisition, and analysis were performed with a custom-made software and with pClamp8.0/ Clampfit (Axon Instruments).
Voltage-dependence of activation and steady-state inactivation, recovery from inactivation, and development of slow inactivation were determined using voltage-clamp protocols described in the relevant figures (Figures 1 -4) . In all protocols, a holding potential of 2120 mV and a cycle time of 5 s was used. Voltage-dependence of activation and inactivation curves were fitted with a Boltzmann func-
), where V 1/2 is the half-maximal voltage of (in)activation, and k is the slope factor. Recovery from inactivation was assessed with a double-pulse protocol. Data were normalized to the current elicited by the first pulse (P 1 ) and fitted with a bi-exponential function (y
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, where A f and A s are the amplitudes of the fast and the slow inactivating components, respectively, and t f and t s are their respective inactivation time constants. Development of slow inactivation was fitted with a single exponential function
, where t is the time constant for the development of slow inactivation, and A is the fraction of channels that enter the slow-inactivated state after a 1000 ms depolarization step. I Na density for NRCs was calculated by dividing maximal peak I Na by cell membrane capacitance (C m ). The mean values for C m were 10.8 + 1.7 pF for untreated NRCs and 9.2 + 1.8 pF for TXL-exposed NRCs.
The bath solution contained (mmol/L): NaCl 140, KCl 4.7, CaCl 2 1.8, MgCl 2 2.0, NaHCO 3 4.3, Na 2 HPO 4 1.4, glucose 11.0, HEPES 16.8, pH adjusted to 7.4 (NaOH). For I Na measurements from NRCs, nifedipine (5 mM) was added to the bath solution. Pipettes were filled with (mmol/L): CsCl 10, CsF 110, NaF 10, EGTA 11, CaCl 2 1, MgCl 2 1, Na 2 ATP2, HEPES 10, pH 7.2 (CsOH).
Western blot analysis
To test for endogenous expression of the b 1 -subunit in HEK293 cells, SCN1B protein expression levels in HEK293 cells were investigated by western blotting (see Supplementary material online).
Immunocytochemistry
Antibodies
The following primary antibodies were used: polyclonal anti-Na v 1.5 (Alomone Laboratories, ASC-005; 1:200), monoclonal anti-calnexin (Chemicon International, MAB3126; 1:1000), and monoclonal anti-a-actinin (Sigma Co.; 1:1000). As secondary antibodies, Alexaconjugated goat anti-mouse and goat anti-rabbit antibodies were used (Molecular Probes, Invitrogen).
Immunocytochemistry and confocal microscopy
Transfected HEK293 cells and NRCs were plated onto laminin-coated glass coverslips and incubated at 378C in the presence or absence of 100 mM TXL. Cells were fixed and stained with the relevant antibodies, as described in the Supplementary material online. Confocal imaging was performed using a Leica SPE confocal laser scanning microscope (scanning Â40 magnification with additional Â3 digital zoom). For double-labelling experiments, dual-colour red and green images were recorded.
Statistical analysis
Results are expressed as mean + SEM. To remove variations from multi-session experiments due to day-to-day differences in Na v 1.5 expression levels in transfected HEK293 cells, a correction factor (calculated as described previously 21 ) was applied to maximal peak I Na .
The corrected data set was used for statistical analysis. Comparisons among groups were performed with two-way analysis of variance (ANOVA). When data were not normally distributed, ANOVA on ranks was used. Two-way ANOVA with repetitive measurements followed by a Holm -Sidak test for post hoc analysis was performed where appropriate. To compare I Na densities during control conditions and after incubation with TXL in NRCs, unpaired Student's t-test was used. P , 0.05 was considered statistically significant. Figure S1 ). Figures 1A and B show representative examples of peak I Na evoked by depolarizing steps from a holding potential of 2120 mV for Na v 1.5 ( Figure 1A ) and Na v 1.5 þ b 1 ( Figure 1B ) under control (CTRL) conditions and after exposure to TXL. Treatment with TXL caused a two-fold reduction in maximal peak I Na in both groups (P ¼ 0.006 for Na v 1.5 and P ¼ 0.04 for Na v 1.5 þ b 1 ; Table 1 ), as can be appreciated from the current traces ( Figure 1A and B) and the average current-voltage relationships ( Figure 1C and D). Moreover, maximal peak I Na was significantly increased for Na v 1.5 þ b 1 compared with Na v 1.5 alone (P ¼ 0.03), in line with previous studies in heterologous expression systems, which showed enhanced I Na in the presence of the b 1 -subunit. 22, 23 To test for the effect of tubulin polymerization on I Na density in a native environment, we also incubated NRCs with 100 mM TXL overnight. As in HEK293 cells, treatment with TXL reduced I Na density by almost a factor of 2 ( Figure 2B ), although the difference did not reach statistical significance. I Na densities under control conditions and after incubation with TXL were 0.9 + 0.3 nA/pF (n ¼ 5) and 0.6 + 0.08 nA/pF (n ¼ 7, P ¼ 0.2), respectively.
Results
Electrophysiology
Effect of increased tubulin polymerization on cardiac Na
1 channel-gating properties in transfected HEK293 cells The effect of TXL treatment on fast inactivation properties was analysed by fitting the decay phase of macroscopic I Na ( Figure 1 ) at various test potentials with a bi-exponential function. Incubation with TXL did not affect the time course of current decay when Na v 1.5 was expressed alone ( Figure 3A) : time constants t f and t s were similar for CTRL and TXL groups at all voltages. TXL-treated Na v 1.5 in the presence of the b 1 -subunit ( Figure 3B ) exhibited significantly smaller t s values at voltages negative to 235 mV compared with CTRL, whereas t f values were similar, indicating that the final part of current inactivation proceeded with a faster time course. The average amplitudes of the fast (A f ) and slow (A s ) inactivating components are depicted in the Supplementary material online, Figure S2 . Irrespective of the presence of the Tubulin polymerization modifies sodium channel function b 1 -subunit, incubation with TXL gave rise to an equal reduction in both A f and A s of 45%, which is comparable with the reduction in current amplitude shown in Figure 1 .
Comparison of the activation and steady-state inactivation parameters-the half-maximal voltage V 1/2 of (in)activation and the slope factor k-between CTRL groups and TXL-treated groups ( Figure 3C and D, Table 1 ) revealed only a small increase in the voltage sensitivity of inactivation by TXL in the Na v 1.5 group, as indicated by a smaller slope factor k (P ¼ 0.045). Voltage-dependent characteristics of activation and inactivation in CTRL conditions were similar for Na v 1.5 þ b 1 and Na v 1.5 channels.
Recovery from inactivation was not modified by treatment with TXL, since the fast and slow time constants (t f and t s ) of the recovery time course were similar to CTRL in both the Na v 1.5 and Na v 1.5 þ b 1 groups (Figure 4A and B; Table 1 ). However, the presence of the b 1 -subunit clearly accelerated the recovery time course of inactivation, when comparing Na v 1.5 with Na v 1.5 þ b 1 under CTRL conditions. This was exclusively due to a reduction in t f value in the Na v 1.5 þ b 1 channels (P ¼ 0.004); values of t s were comparable.
During sustained depolarization, Na v 1.5 undergoes a slower inactivation process termed 'slow inactivation', a conformational state distinct from fast inactivation, which requires a prolonged period of hyperpolarization to recover from, and influences channel availability at fast heart rates. 17, 18 After exposure to TXL, the fraction of channels (A) that slow inactivated at the end of a 1000 ms depolarization step was significantly reduced (A ¼ 0.18, calculated as 1 minus normalized I Na ) with respect to CTRL (A ¼ 0.31) in the Na v 1.5 group (P ¼ 0.009, Figure 4C , Table 1 ) and comparable with the degree of slow inactivation observed in the Na v 1.5 þ b 1 group (A ¼ 0.22) under CTRL conditions ( Figure 4D , Table 1 ). Besides, TXL treatment was also responsible for an approximately two-fold decrease in the rate of development of slow inactivation (t) (P ¼ 0.001, Figure 4C , Table 1 ). These effects of TXL were abolished in the presence of the b 1 -subunit, since both the amount and the rate of slow inactivation were similar under CTRL and TXL-treated conditions in Na v 1.5 þ b 1 ( Figure 4D , A, fraction of channels that enter the slow-inactivated state after a 1000 ms depolarizing step; k, slope factor of voltage dependence of (in)activation; t, time constant for the development of slow inactivation; t f and t s , fast and slow time constants of recovery from inactivation; V in Na v 1.5 than in Na v 1.5 þ b 1 (P ¼ 0.03), whereas t was similar for both groups ( Figure 4C and D, Table 1 ). Modifications in fast inactivation properties, e.g. caused by mutations in the SCN5A gene (long-QT syndrome type 3) or by pathological conditions such as HF, can result in a persistent inward sodium current (I NaL ). I NaL was measured as a tedrodotoxin-sensitive current during trains of ventricular AP used as voltage-clamp command (Supplementary material online, Figure S3 ). In the voltage range of the AP, incubation with TXL did not affect I NaL , irrespective of the presence of the b 1 -subunit.
In conclusion, the present data show that enhanced tubulin polymerization impairs cardiac Na þ channel fast and slow inactivation and decreases I Na amplitude.
Immunocytochemistry 3.2.1 Effect of increased tubulin polymerization on cardiac Na 1 channel membrane expression
To establish whether the reduction in I Na amplitude reflects a reduction in the number of channels in the plasma membrane or is due to the presence of a population of non-functional channels, immunocytochemical analysis was performed in transfected HEK293 cells and NRCs, after they had been treated with TXL. HEK293 cells were stained with antibodies against Na v 1.5 and the endoplasmic reticulum (ER) transmembrane protein calnexin. Cells transfected with SCN5A alone showed a faint but distinguishable rim of Na v 1.5 staining surrounding the intracellular calnexin staining, indicating successful Na v 1.5 surface expression ( Figure 5A ). After treatment with TXL, cells transfected with SCN5A alone did not show any discernable membrane labelling, and only diffuse intracellular staining for Na v 1.5 was observed ( Figure 5B ). Co-transfection with SCN5A and the b 1 -subunit resulted in a more intense membrane labelling for Na v 1.5 compared with SCN5A alone ( Figure 5A and C ) , suggesting that the b 1 -subunit enhances I Na amplitude through promoting membrane Na v 1.5 expression. Treatment with TXL clearly reduced Na v 1.5 membrane-labelling intensity in co-transfected cells ( Figure 5D) . However, faint cell-surface expression was still observed in these cells, demonstrating that TXL did not completely inhibit Na v 1.5 membrane expression.
Similar results were obtained in NRCs. Untreated NRCs ( Figure 6 , left panel) displayed Na v 1.5 staining within the cytoplasm, as well as on the cell membrane, indicating the presence of Na þ channels on the myocyte surface. In accordance with the observed reduction in I Na density, TXL-treated NRCs ( Figure 6 , right panel) displayed reduced cell-surface Na v 1.5 labelling, suggesting reduced trafficking of Na þ channels to the myocyte cell membrane after incubation with TXL.
Discussion
Although the importance of an intact cytoskeleton for correct functioning of voltage-gated Na þ channels is increasingly recognized, 3 -9 few studies report on how microtubule derangement, 4, 9 in particular tubulin polymerization, 4 impacts on cardiac Na þ channel activity. Our investigation revealed that enhanced tubulin polymerization by the anticancer agent TXL both decreased Na v 1.5 membrane expression, leading to an approximately two-fold reduction in I Na amplitude, and modified its gating properties.
Effect of increased tubulin polymerization on cardiac Na 1 channel membrane expression
Microtubules, which constitute a major component of the cytoskeleton, are cylindrical polymers formed by heterodimers of a-and b-tubulin, which can rapidly polymerize and depolymerize in a constant dynamic equilibrium. The energy for microtubule polymerization is derived from the hydrolysis of a guanosinetriphosphate (GTP) molecule bound to b-tubulin. 19 TXL is a microtubulebinding drug that suppresses this dynamic behaviour by increasing the polymerization rate and stabilizing microtubules against depolymerization at the expense of free tubulin. 19 The main finding of this study is that increased tubulin polymerization markedly reduces peak I Na amplitude both in HEK293 cells and NRCs. Although co-expression with the b 1 -subunit increased I Na in HEK293 cells, the TXL-induced current reduction was independent of the b 1 -subunit since I Na amplitudes were decreased by 50% both in Na v 1.5 and in Na v 1.5 þ b 1 (Figure 1) . The reduced membrane-labelling intensity observed in both HEK293 cells and NRCs stained with anti-Na v 1.5 antibody (Figures 5 and 6 ) strongly suggests a reduction in the number of functional Na v 1.5 in the sarcolemma. To our knowledge, this is the first study to show that enhanced tubulin polymerization leads to reduced Na v 1.5 membrane expression. Patch-clamp studies performed in rat ventricular myocytes pre-treated with TXL have previously shown changes in Na þ channel-gating properties, but have not investigated I Na density. 4 The mechanism(s) underlying reduction in Na v 1.5 membrane expression upon tubulin polymerization in our study remains to be resolved, but several can be postulated. First, given the key role played by microtubules in regulating channel protein trafficking, 24 enhanced tubulin polymerization could interfere with Na þ channel transportation from the ER to the Golgi apparatus and then to the sarcolemma, a tightly regulated process not yet completely elucidated. 25 In particular, Na v 1.5 interaction with tubulin, directly or through auxiliary proteins, as well as the dynamics of Na v 1.5 trafficking along microtubules, is still unknown. Such a physical interaction, however, does exist for tubulin and other cardiac ion channels, e.g. the human ether-a-go-go potassium channel type 2 (heag2), 26 and KCNQ1, which is responsible for the slow component of the delayed rectifier potassium (K þ ) current. 27 Nevertheless, TXL treatment had no effect on KCNQ1 channel properties and it modified only heag2 channel activation time, Peak sodium currents elicited by P 2 were normalized (P 2 /P 1 ) and plotted as a function of the recovery interval Dt. Inset: two-pulse protocol. Development of slow inactivation for Na v 1.5 (C) and Na v 1.5 þ b 1 (D) under CTRL conditions and after incubation with TXL. Peak sodium currents elicited by P 2 were normalized (P 2 /P 1 ) and plotted as a function of the duration of the conditioning step (P 1 ). Inset: two-pulse protocol.
without affecting current density. Similarly, incubation of rat ventricular myocytes with TXL did not alter L-type calcium current magnitude, although it did cause functional effects. 28, 29 From these data, we may speculate that reduced channel expression due to microtubule stabilization could be specifically related to the cardiac Na þ channel.
Second, the effect of increased microtubule polymerization by TXL on Na v 1.5 expression might be explained by the acceleration of Na v 1.5 internalization, directly or through the modulation of other proteins. Indeed, exposure to nocodazole, a microtubuledepolymerizing agent, caused an increase in the density of the ultra-rapid delayed rectifier K þ current in rat atrial myocytes through the enhancement of K v 1.5 channel membrane expression. Nocodazole exerted its effect by interfering with the normal retrograde trafficking of the K v 1.5 channels along the microtubules. Tubulin polymerization modifies sodium channel function specialized membrane domains. Accordingly, the observed I Na reduction could be due to an impaired anchoring of the channel to the plasma membrane following tubulin polymerization. Finally, Na v 1.5 release from caveolae and/or ER may be impaired through a reduction in free tubulin, following treatment with TXL. It has been shown that free tubulin dimers may directly transfer GTP to G proteins (guanine nucleotide-binding proteins), preferentially stimulatory G proteins (Gs) at physiological temperatures, 34, 35 which then dissociate into a and bg subunits. Gas subsequently can stimulate the basal activity of the intracellular effector adenylate cyclase (AC). 34, 35 AC then may transform AMP into cAMP, which, in turn, activates protein kinase A (PKA). The latter has been shown to increase I Na amplitude and was suggested to exert its effect through recruitment of Na þ channels from the ER and/or from caveolae, small invaginations of the plasma membrane which act as local storage of Na v 1.5.
36,37
Thus, in our study, a reduction in free tubulin due to increased polymerization by incubation with TXL (378C) should eventually result in a reduced basal activity of PKA proteins, through a Gas/AC/cAMP-pathway, that might impair Na v 1.5 release from caveolae and/or ER. Alternatively, reduced Gas may directly modulate Na þ channel density. were observed for the neuronal and skeletal muscle Na þ channel isoform upon exposure to agents that disrupt microtubule formation. 7, 8 Moran et al. 8 reported a small increase in the time constant of inactivation, and Shcherbatko et al. 7 showed an acceleration of the spontaneous transition from slow to fast inactivation kinetics as observed during recording of I Na in the macropatch configuration. Tubulin polymerization by TXL was reported to enhance the spontaneous negative shift of voltage dependence of activation observed in time in long-lasting whole-cell recordings of rat ventricular myocytes. 4 In our study, TXL did not affect voltage dependencies of activation and inactivation, but altered the kinetics of both the fast and slow inactivation processes. We found that tubulin polymerization significantly accelerated the final phase (t s ) of fast inactivation, an effect that was observed only in the presence of the b 1 -subunit ( Figure 3A and B) . In contrast, modulation of slow inactivation was revealed only in the absence of the b 1 -subunit ( Figure 4C and D) . In Na v 1.5, slow inactivation developed with a time course similar to that of Na v 1.5 þ b 1 ; however, the propensity of channels to reside in the slow-inactivated state almost doubled, suggesting destabilization of the slow inactivation process by the b 1 -subunit. Moreover, in Na v 1.5, TXL treatment strongly slowed down the time course of slow inactivation and reduced the fraction of channels that reside in the slow-inactivated state to a level similar to that found in Na v 1.5 þ b 1 ( Figure 4C and D) . In contrast, TXL had no effect on the Na v 1.5 þ b 1 group. Taken all together, our findings raise the intriguing idea that the b 1 -subunit modulates Na v 1.5 inactivation gating via interaction with the microtubule cytoskeleton. Besides, they seem to confirm the concept that fast and slow inactivation are kinetically and structurally two different processes.
39 Figure 6 Confocal immunofluorescence of the a-subunit of cardiac sodium channel (Na v 1.5) and the cytoskeletal protein a-actinin in neonatal rat cardiomyocytes (NRCs) during control (CTRL) conditions and after incubation with 100 mM TXL. Untreated NRCs (left panel) show Na v 1.5 staining (green) within the cytoplasm, as well as on the cell membrane (indicated by arrows), indicating the presence of sodium channels on the myocyte surface. In contrast, TXL-treated NRCs (right panel) display mostly cytoplasmic Na v 1.5 staining without clear cell-surface labelling for Na v 1.5. Scale bars indicate 25 mm.
